tranylcypromine has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, C; He, M; Hu, Z; Huang, J; Ning, W; Zhou, HB | 1 |
| Barrow, D; Eissa, AG; Foster, PA; Gee, J; Powell, LE; Simons, C | 1 |
2 other study(ies) available for tranylcypromine and Breast Cancer
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of novel dual-acting modulators targeting both estrogen receptor α (ERα) and lysine-specific demethylase 1 (LSD1) for treatment of breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Survival; Chemistry Techniques, Synthetic; Drug Design; Estrogen Receptor alpha; Heterocyclic Compounds, 2-Ring; Histone Demethylases; Humans; MCF-7 Cells; Models, Molecular; Molecular Targeted Therapy; Protein Conformation | 2020 |
4th generation nonsteroidal aromatase inhibitors: An iterative SAR-guided design, synthesis, and biological evaluation towards picomolar dual binding inhibitors.
Topics: Aromatase; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Receptors, Estrogen; Triazoles | 2022 |